QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (107) Citing Articles via Google Scholar Google Scholar Articles by Le, W.-d. Articles by Appel, S. H. Search for Related Content PubMed PubMed Citation Articles by Le, W.-d. Articles by Appel, S. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DOPAMINE HYDROGEN PEROXIDE NITRIC OXIDE Medline Plus Health Information Parkinson's Disease Patient Rights

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 1, 2001, 21(21):8447-8455

Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson's Disease

Wei-dong Le, Dominic Rowe, Wenjie Xie, Irving Ortiz, Yi He, and Stanley H. Appel

Department of Neurology, Baylor College of Medicine, Houston, Texas 77030

Microglial activation and oxidative stress are significant components of the pathology of Parkinson's disease (PD), but their exact contributions to disease pathogenesis are unclear. We have developed an in vitro model of nigral injury, in which lipopolysaccharide-induced microglial activation leads to injury of a dopaminergic cell line (MES 23.5 cells) and dopaminergic neurons in primary mesencephalic cell cultures. The microglia are also activated by PD IgGs in the presence of low-dose dopa-quinone- or H₂O₂-modified dopaminergic cell membranes but not cholinergic cell membranes. The activation requires the microglial FcR receptor as demonstrated by the lack of activation with PD IgG Fab fragments or microglia from FcR/ mice. Although microglial activation results in the release of several cytokines and reactive oxygen species, only nitric oxide and H₂O₂ appear to mediate the microglia-induced dopaminergic cell injury. These studies suggest a significant role for microglia in dopaminergic cell injury and provide a mechanism whereby immune/inflammatory reactions in PD could target oxidative injury relatively specifically to dopaminergic cells.

Key words: inflammatory; microglia; IgG; oxidative stress; DAergic neurons; Parkinson's disease

---

Copyright © 2001 Society for Neuroscience  0270-6474/01/21218447-09$05.00/0

This article has been cited by other articles:

				R. Zhang, S. Xu, Y. Cai, M. Zhou, X. Zuo, and P. Chan Ganoderma lucidum Protects Dopaminergic Neuron Degeneration Through Inhibition of Microglial Activation Evid. Based Complement. Altern. Med., July 16, 2009; (2009) nep075v1. [Abstract] [Full Text] [PDF]

				M. Monif, C. A. Reid, K. L. Powell, M. L. Smart, and D. A. Williams The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore J. Neurosci., March 25, 2009; 29(12): 3781 - 3791. [Abstract] [Full Text] [PDF]

				D. R. Beers, J. S. Henkel, Q. Xiao, W. Zhao, J. Wang, A. A. Yen, L. Siklos, S. R. McKercher, and S. H. Appel Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis PNAS, October 24, 2006; 103(43): 16021 - 16026. [Abstract] [Full Text] [PDF]

				P. Jenner and C. W. Olanow The pathogenesis of cell death in Parkinson's disease Neurology, May 23, 2006; 66(10_suppl_4): S24 - S36. [Abstract] [Full Text]

				S.-L. Hsuan, H. M. Klintworth, and Z. Xia Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways. J. Neurosci., April 26, 2006; 26(17): 4481 - 4491. [Abstract] [Full Text] [PDF]

				Y. Zhou, Y. Wang, M. Kovacs, J. Jin, and J. Zhang Microglial Activation Induced by Neurodegeneration: A Proteomic Analysis Mol. Cell. Proteomics, October 1, 2005; 4(10): 1471 - 1479. [Abstract] [Full Text] [PDF]

				D. M. Thomas and D. M. Kuhn Cyclooxygenase-2 Is an Obligatory Factor in Methamphetamine-Induced Neurotoxicity J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 870 - 876. [Abstract] [Full Text] [PDF]

				R. B. Rock, G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson Role of Microglia in Central Nervous System Infections Clin. Microbiol. Rev., October 1, 2004; 17(4): 942 - 964. [Abstract] [Full Text] [PDF]

				E. P. Simpson, Y. K. Henry, J. S. Henkel, R. G. Smith, and S. H. Appel Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden Neurology, May 25, 2004; 62(10): 1758 - 1765. [Abstract] [Full Text] [PDF]

				S.-H. Choi, E. H. Joe, S. U. Kim, and B. K. Jin Thrombin-Induced Microglial Activation Produces Degeneration of Nigral Dopaminergic Neurons In Vivo J. Neurosci., July 2, 2003; 23(13): 5877 - 5886. [Abstract] [Full Text] [PDF]

				T. Harada, C. Harada, S. Kohsaka, E. Wada, K. Yoshida, S. Ohno, H. Mamada, K. Tanaka, L. F. Parada, and K. Wada Microglia-Muller Glia Cell Interactions Control Neurotrophic Factor Production during Light-Induced Retinal Degeneration J. Neurosci., November 1, 2002; 22(21): 9228 - 9236. [Abstract] [Full Text] [PDF]

				P. A. Serra, L. Sciola, M. R. Delogu, A. Spano, G. Monaco, E. Miele, G. Rocchitta, M. Miele, R. Migheli, and M. S. Desole The Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induces Apoptosis in Mouse Nigrostriatal Glia. RELEVANCE TO NIGRAL NEURONAL DEATH AND STRIATAL NEUROCHEMICAL CHANGES J. Biol. Chem., September 6, 2002; 277(37): 34451 - 34461. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help